A new cost-effectiveness framework for modeling psoriasis treatments
As more psoriasis treatments come to market in both new and existing drug classes, health care payers will need assistance in determining the most cost-effective regimen or sequence of regimens to control budgets. We sought to devise a cost-effectiveness modeling structure that will aid in decision making by highlighting differentiating factors between drugs and meet the changing needs of payers.
Graham, C., Mollon, P., Miles, L., & McBride, D. (2015). A new cost-effectiveness framework for modeling psoriasis treatments. Value in Health, 18(3), A20-A20. https://doi.org/10.1016/j.jval.2015.03.126